- Home
- OABI vs CCIX Comparison
OABI vs CCIX Comparison
Compare OABI & CCIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OABI
- CCIX
- Stock Information
- Founded
- OABI 2012
- CCIX 2023
- Country
- OABI United States
- CCIX United States
- Employees
- OABI N/A
- CCIX N/A
- Industry
- OABI Biotechnology: Pharmaceutical Preparations
- CCIX
- Sector
- OABI Health Care
- CCIX
- Exchange
- OABI Nasdaq
- CCIX Nasdaq
- Market Cap
- OABI 459.1M
- CCIX 367.7M
- IPO Year
- OABI N/A
- CCIX 2024
- Fundamental
- Price
- OABI $3.85
- CCIX $10.20
- Analyst Decision
- OABI Strong Buy
- CCIX
- Analyst Count
- OABI 4
- CCIX 0
- Target Price
- OABI $9.00
- CCIX N/A
- AVG Volume (30 Days)
- OABI 509.5K
- CCIX 90.6K
- Earning Date
- OABI 11-12-2024
- CCIX 01-01-0001
- Dividend Yield
- OABI N/A
- CCIX N/A
- EPS Growth
- OABI N/A
- CCIX N/A
- EPS
- OABI N/A
- CCIX N/A
- Revenue
- OABI $20,409,000.00
- CCIX N/A
- Revenue This Year
- OABI N/A
- CCIX N/A
- Revenue Next Year
- OABI $71.78
- CCIX N/A
- P/E Ratio
- OABI N/A
- CCIX N/A
- Revenue Growth
- OABI N/A
- CCIX N/A
- 52 Week Low
- OABI $3.56
- CCIX $10.00
- 52 Week High
- OABI $6.72
- CCIX $11.17
- Technical
- Relative Strength Index (RSI)
- OABI 40.94
- CCIX N/A
- Support Level
- OABI $3.62
- CCIX N/A
- Resistance Level
- OABI $4.19
- CCIX N/A
- Average True Range (ATR)
- OABI 0.23
- CCIX 0.00
- MACD
- OABI -0.06
- CCIX 0.00
- Stochastic Oscillator
- OABI 18.40
- CCIX 0.00
About OABI OmniAb Inc.
OmniAb Inc offers therapeutic antibody discovery technologies. The company focuses on enabling the rapid development of therapeutics by pushing the frontiers of drug discovery technologies. Its technology platform is designed to enable the efficient discovery of high-quality, fully human antibodies for a wide range of diseases. The heart of the OmniAb technology platform is the Biological Intelligence of its proprietary transgenic animals, including OmniRat, OmniMouse, and OmniChicken, that have been genetically modified to generate antibodies with human sequences which are naturally optimized through in vivo affinity maturation.
About CCIX Churchill Capital Corp IX Ordinary Shares
Churchill Capital Corp IX is a blank check company.